Dr Michael Thorpy Discusses Pharmacological Pathways for Idiopathic Hypersomnia
Despite the condition of idiopathic hypersomnia being around for quite some time, the first FDA approval for a drug to treat it was not until 2021, said Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine. The latest research in …